# Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen

> **NCT00774280** · PHASE3 · COMPLETED · sponsor: **Cooperative Study Group A for Hematology** · enrollment: 130 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** BuCy vs BuFlu

## Key facts

- **NCT ID:** NCT00774280
- **Lead sponsor:** Cooperative Study Group A for Hematology
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2009-11
- **Final completion:** 2010-12
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2011-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774280, "Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00774280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*